Combined treatment with surfactant and specific immunoglobulin reduces bacterial proliferation in experimental neonatal group B streptococcal pneumonia

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 6, 1999, Pages 1862-1867

  Herting, Egbert ^a,b   Gan, Xiaozhuang ^a,b   Rauprich, Petra ^a,b   Jarstrand, Connie ^a,b   Robertson, Bengt ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LUNG SURFACTANT EXTRACT; POLYCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL GROWTH; BLOOD CULTURE; BODY WEIGHT; CARBON DIOXIDE TENSION; CONTROLLED STUDY; HEART RATE; INTRATRACHEAL DRUG ADMINISTRATION; LUNG ALVEOLUS SURFACE TENSION; LUNG COMPLIANCE; LUNG FUNCTION; LUNG HOMOGENATE; LUNG LAVAGE; NEWBORN; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RABBIT; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

EID: 0033033680     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.6.9810047     Document Type: Article

References (34)

1. 1. Weisman, L. E., B. J. Stoll, D. F. Cruess, R. T. Hall, G. B. Merenstein, V. G. Hemming, and G. W. Fischer. 1992. Early onset group B-streptococcal sepsis: a current assessment. J. Pediatr. 121:428-433.
2. 2. Ablow, R., S. Driscoll, E. L. Effmann, I. Gross, C. J. Jolles, R. Uauy, and J. B. Warshaw. 1976. A comparison of early onset group B streptococcal neonatal infection and the respiratory distress syndrome. N. Engl. J. Med. 294:65-70.
3. 3. Herting, E., C. Jarstrand, O. Rasool, T. Curstedt, B. Sun, and B. Robertson. 1994. Experimental neonatal group B streptococcal pneumonia: effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits. Pediatr. Res. 36:784-791.
4. 4. Herting, E., B. Sun, C. Jarstrand, T. Curstedt, and B. Robertson. 1997. Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia. Arch. Dis. Child. 76:F3-F8.
5. 5. Auten, R. L., R. H. Notter, J. W. Kendig, J, M. Davis, and D. L. Shapiro. 1991. Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 87:101-107.
6. 6. Khammash, H., M. Perlman, J. Wojtulewicz, and M. Dunn. 1993. Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics 92:135-139.
7. 7. Lotze, A., B. R. Mitchell, D, I. Bulas, E. M. Zola, R. A. Shalwitz, and J. H. Gunkel. 1998. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure: Survanta in Term Infants Study Group. J. Pediatr. 132:40-47.
8. 8. Baker, C. J. 1997. Group B streptococcal infections. Clin. Perinatol. 24:59-70.
9. 9. Schuchat, A., C. Whitney, and K. Zangwilt. 1996. Prevention of perinatal group B streptococcal disease: a public health perspective. M.M.W.R. 45:1-24.
10. 10. American Academy of Pediatrics: Committee on infectious diseases and Committee on fetus and newborn. 1997. Revised guidelines for prevention of early-onset group B-streptococcal (GBS) infection. Pediatrics 99:489-496.
11. 11. Jelinkovà, J. 1977. Group B streptococci in the human population. Curr. Top. Microbiol. Immunol. 76:126-165.
12. 12. Herting, E., C. Jarstrand, O. Rasool, T. Curstedt, S. Håkansson, and B. Robertson. 1995. Effect of surfactant on nitroblue tetrazolium (NBT) reduction of polymorphonuclear leucocytes stimulated with type Ia group B streptococci. Acta Paediatr. 84:922-926.
13. 13. Collaborative European Mullicenter Study Group. 1988. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics 82:683-691.
14. 14. Sun, B., T. Kobayashi, T. Curstedt, G. Grossmann, and B. Robertson. 1991. Application of a new ventilalor-multi-plethysmograph system for testing efficacy of surfactant replacement in newborn rabbits. Eur. Respir. J. 4:364-370.
15. 15. Hill, H. R., D. K. Kelsey, L. A. Gonzales, and H. V. Raff. 1992. Monoclonal antibodies in the therapy of experimental neonatal group B streptococcal disease. Clin. Immunol. Immunopathol. 62:87-91.
16. 16. Weisman, L. E., B. F. Anthony, V. G. Hemming, and G. W. Fischer. 1993. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates. J. Pediatr. 122:929-937.
17. 17. Seeger, W., G. Stöhr, H. R. D. Wolf, and H. Heuhof. 1985. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J. Appl. Physiol. 58:326-338.
18. 18. Rimensberger, P. C., A. Burek-Kozlowska, A. Morell, D. Germann, A. K. Eigenmann, F. Steiner, R. Burger, M. Kuenzli, and U. B. Schaad. 1995. Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants. Pediatr. Infect. Dis. J. 15:209-216.
19. 19. Walmrath, D., A. Günther, H. A. Ghofrani, R. Schermuly, T. Schneider, F. Grimminger, and W. Seeger. 1996. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am. J. Respir. Crit. Care Med. 154:57-62.
20. 20. Sherman, M. P., J. D'Ambola, E. Aeberhard, and C. T. Barrett. 1988. Surfactant therapy of newborn rabbits impairs lung macrophage bactericidal activity. J. Appl. Physiol. 65:137-145.
21. 21. Sherman, M. P., L. A. Campbell, T. A. Merritt, T. Curstedt, W. A. Long, J. H. Gunkel, and B. Robertson. 1994. Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits. J. Pediatr. 125:939-947.
22. 22. Van Iwaarden, J. F. 1993. Surfactant and the pulmonary defense system. In B. Robertson, L. M. G. van Golde, and J. J. Batenburg, editors. Pulmonary Surfactant: From Molecular Biology to Clinical Practice. Elsevier, Amsterdam. 215-225.
23. 23. Song, G. W., B. Robertson, T. Curstedt, X. Z. Gan, and W. X. Huang. 1996. Surfactant treatment in experimental Escherichia coli pneumonia. Acta Anaesthesiol. Scand. 40:1152-1159.
24. 24. Eijking, E. P., G. J. van Daal, R. Tenbrinck, A. Luijendijk, J. F. Sluiters, E. Hannapel, and B. Lachmann. 1991, Effect of surfactant replacement on pneumocystis carinii pneumonia in rats. Intensive Care Med. 17:475-478.
25. 25. Van Daal, G. J., K. L. So, D. Gommers, E. P. Eijking, R. B. Fievez, M. J. Sprenger, D. W. van Dam, and B. Lachmann. 1991. Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia. Anesth. Analg. 72:589-595.
26. 26. Van Daal, G. J., J. A. H. Bos, E. P. Eijking, D. Gommers, E. Hannapel, and B. Lachmann. 1992. Surfactant replacement therapy improves pulmonary mechanics in end-stage influenza A pneumonia in mice. Am. Rev. Respir. Dis. 145:859-863.
27. 27. LeVine, A. M., M. D. Bruno, K. M. Huelsman, G. F. Ross, J. A. Whitsett, and T. R. Korfhagen. 1997. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J. Immunol. 158:4336-4340.
28. 28. Herting, E., D. S. Strayer, C. Jarstrand, B. Sun, and B. Robertson. 1998. Lung function and bacterial proliferation in experimental neonatal pneumonia in ventilated rabbits exposed to monoclonal antibody to surfactant protein A. Lung 176:123-131.
29. 29. Kharasch, V. S., T. D. Sweency, J. Fredberg, J. Lehr, A. I. Damokosh, M. E. Avery, and J. D. Brain. 1991. Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs. Am. Rev. Respir. Dis. 144:909-913.
30. 30. van't Veen, A., J. W. Mouton, D. Gommers, and B. Lachmann. 1996. Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae. Br. J. Pharmacol. 119:1145-1148.
31. 31. Sherman, M. P., S. L. Hall, J. T. Johnson, and E. E. Aeberhard. 1993. Formulating a surfactant therapy for preterm infants who have bacterial pneumonia and respiratory distress syndrome. In G. Bevilacqua, S. Parmigiani, and B. Robertson, editors. Surfactant in Clinical Practice. Harwood Academic Publishers, London, 103-111.
32. 32. Walther, F. J., C. U. R. David, and S. L. Lopez. 1995. Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. Am. J. Physiol. 269:L613-L617.
33. 33. Fajardo, C., D. Levin, M. Garcia, D. Abrams, and I. Adamson. 1998. Surfactant versus saline as a vehicle for corticosteroid delivery to the lungs of ventilated rabbits. Pediatr. Res. 43:542-547.
34. 34. Katkin, J. P., R. C. Husser, C. Langston, and S. T. E. Welty. 1997. Exogenous surfactant enhances the delivery of recombinant adenoviral vectors to the lung. Human Gene Therapy 8:171-185.